Transcriptome sequencing-based comparison of Myeloproliferative Neoplasms, with and without driver mutations, to identify molecular targets in triple-negative MPNs for precision therapy development
2023 - 2026
Dr Sweta Srivastava
Dr Sweta S, Dr Cecil Ross, Dr Seetharam, Dr Hari
ongoing
PI